![](/img/cover-not-exists.png)
A15Eph A2 expression is a predictive biomarker of poorer activity and efficacy of FOLFIRI + cetuximab in RAS WT metastatic colorectal cancer (mCRC) patients (pts) in the CAPRI GOIM trial
Cardone, C, Paul, M C, Moreno-Viedma, V, Martini, G, Vitiello, P P, Ciardiello, D, Sforza, V, Troiani, T, Napolitano, S, Vitale, P, Zanaletti, N, Rachiglio, A M, Rizzi, D, Maiello, E, Normanno, N, SibVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx422.014
Date:
October, 2017
File:
PDF, 68 KB
english, 2017